Bliss GVS Pharma Limited Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Bliss GVS Pharma Limited Company Profile :

Bliss GVS Pharma Limited is an Indian company engaged in developing, manufacturing and marketing pharmaceutical formulations.

The Company offers a range of suppositories and pessaries in various therapeutic categories, including women’s health, which consists of anti-fungal, anti-bacterial, contraceptive and lubricants; gastro-intestinal basket, which consists of anti-hemorrhoid, laxatives, anti-inflammatory and anti-emetic, and anti-malarial, which consists of artesunate suppositories.


Bliss GVS Pharma ResultsBSE Code : 506197
NSE Symbol : BLISSGVS
ISIN No. : INE416D01022
Industry : Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Bliss GVS Pharma or you are an stock market analyst then i am sure you might for Quarterly Results of Bliss GVS Pharma.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Bliss GVS Pharma. That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of v.

Bliss GVS Pharma Q1 Results 2017-18 :

Bliss GVS Pharma will announce its Q1 FY 2017-18 Results in August 2017. Will soon update the below mentioned table.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Bliss GVS Pharma will announce its Q2 FY 2017-18 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Bliss GVS Pharma will announce its Q3 FY 2017-18 Results in the month of January 2018.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Bliss GVS Pharma will announce its Q4 FY 2017-18 Results in the month of April 2018.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Bliss GVS Pharma will announce its FY 2017-18 Results in the month of April 2018.

(Values in Cr.) FY 2017-18 Standalone FY 2017-18 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Bliss GVS Pharma Previous Year’s Results (FY 2016-17) :

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : If you like this information about Bliss GVS Pharma Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.